The aim of our study was to retrospectively assess the efficacy and safety of systemic treatments in patients with alopecia areata, by recruiting cases from the HUGO network (Hôpitaux Universitaires du Grand Ouest), a network of 5 hospitals : Brest, Nantes, Rennes, Angers and Tours.
Study Type
OBSERVATIONAL
Enrollment
250
Chu Brest
Brest, France
Short-term efficacy and security of systemic treatments
Response rates including complete response or partial response or no response for each modality of treatment. and Side effects rate
Time frame: From January 2010 to December 2020
Long-term efficacy of systemic treatments
Among responders (CR and PR), the maintained response rate and relapse rate
Time frame: From January 2010 to December 2020
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.